IκBζ is a key driver in the development of psoriasis
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Psoriasis is a common immune-mediated, chronic, inflammatory skin disease characterized by hyperproliferation and abnormal differentiation of keratinocytes and infiltration of inflammatory cells. Although TNFα- and IL-17A-targeting drugs have recently proven to be highly effective, the molecular mechanism underlying the pathogenesis of psoriasis remains poorly understood. We found that expression of the atypical IκB member IκB (inhibitor of NF-κB) ζ, a selective coactivator of particular NF-κB target genes, was strongly increased in skin of patients with psoriasis. Moreover, in human keratinocytes IκBζ was identified as a direct transcriptional activator of TNFα/IL-17A-inducible psoriasis-associated proteins. Using genetically modified mice, we found that imiquimod-induced psoriasis-like skin inflammation was completely absent in IκBζ-deficient mice, whereas skin inflammation was still inducible in IL-17A- and TNFα-deficient mice. IκBζ deficiency also conferred resistance against IL-23-induced psoriasis. In addition, local abrogation of IκBζ function by intradermal injection of IκBζ siRNA abolished psoriasis-like skin inflammation. Taken together, we identify IκBζ as a hitherto unknown key regulator of IL-17A-driven effects in psoriasis. Thus, targeting IκBζ could be a future strategy for treatment of psoriasis, and other inflammatory diseases for which IL-17 antagonists are currently tested in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IκBζ is implicated in psoriasis both genetically and functionally”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Johansen et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165 · cited 1×
“The transcription factor NF-κB has been implicated in several inflammatory diseases, including psoriasis, by activating a huge number of target genes (11, 12).”
BackgroundNestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176 · cited 4×
“The back of the mice was scored clinically for psoriatic symptoms such as scaling, erythema, and thickness on a scale from 0 (no alteration) to 4 (very distinct alteration) as previously described (23).”
BackgroundMethodResultInfluentialDevelopment, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035 · cited 3×
“IL-17F is another IL-17 family member produced by Th17 cells (27).”
BackgroundSecukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862 · cited 1×
“IL-22 is a cytokine produced by Th17 and Th22 cells known to play an important role in psoriasis pathogenesis (3, 34, 35).”
BackgroundLowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650 · cited 8×
“These T cells secrete an array of specific cytokines, including TNFα, IFNγ, IL-17A, IL-17F, and IL-22 (2, 3).”
BackgroundInfluentialThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · cited 1×
“The adaptor protein Act1 is one of the key components in the IL-17 signaling pathway (44), and recently Act1-mediated signaling was demonstrated to play an essential role in imiquimodinduced psoriasis-like skin inflammation (45).”
BackgroundAnti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160 · cited 1×
“Tnf mice were derived as described (48) and backcrossed to the C57BL/6 strain for at least 10 generations.”
MethodBoniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864 · cited 1×
“Because IL-22 is known to act on keratinocytes by stimulating their proliferation (38), these results could explain the lack of keratinocyte proliferation (Ki67 staining) observed in IκBζ-deficient mice after imiquimod treatment, which was not observed in IL-17A–deficient mice.”
BackgroundSano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686 · cited 4×
“It is rapidly induced by certain inflammatory stimuli, including IL17A, but only to a minor extent by TNFα stimulation (10, 14, 16).”
BackgroundInfluentialAmelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., Fuentes-Duculan, J., Novitskaya, I., Khatcherian, A., Bluth, M. J., Lowes, M. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071094 · Cited by 676 · cited 1×
“IL-22 is a cytokine produced by Th17 and Th22 cells known to play an important role in psoriasis pathogenesis (3, 34, 35).”
BackgroundIL-17C regulates the innate immune function of epithelial cells in an autocrine manner
Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z., Jeet, S., Lesch, J., Hackney, J., Kim, J., Zhou, M., Lai, J., et al. (2011) · Nature Immunology · doi:10.1038/ni.2156 · Cited by 477 · cited 1×
“The mechanism by which imiquimod induces psoriasis-like skin inflammation is not fully understood, although IL-17 cytokines like IL-17A, IL-17C, and IL-17F are believed to play important roles (23, 43).”
BackgroundPerera, G. K., Di Meglio, P., & Nestle, F. O. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132448 · Cited by 462
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ
Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Kuwata, H., Takeuchi, O., Takeshige, K., et al. (2004) · Nature · doi:10.1038/nature02738 · Cited by 460
Wolk, K., Haugen, H. S., Xu, W., Witte, E., Waggie, K., Anderson, M., vom Baur, E., Witte, K., Warszawska, K., Philipp, S., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0457-0 · Cited by 412
Li, B., Tsoi, L. C., Swindell, W. R., Gudjonsson, J. E., Tejasvi, T., Johnston, A., Ding, J., Stuart, P. E., Xing, X., Kochkodan, J. J., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.28 · Cited by 397
Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor
Chang, S. H., Park, H., & Dong, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600256200 · Cited by 356 · cited 1×
“Although IL-17 has been demonstrated to regulate IκBζ through an Act1-dependent mechanism in mice (46, 47) and humans (19), the exact signaling mechanism involved needs still to be determined.”
BackgroundCharacterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
Johansen, C., Usher, P. A., Kjellerup, R. B., Lundsgaard, D., Iversen, L., & Kragballe, K. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08902.x · Cited by 352 · cited 1×
“IL-17F is known to be elevated in lesional psoriatic skin (27, 42) as well as in mice skin treated with imiquimod (23).”
BackgroundSelf-citationFumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Ghoreschi, K., Brück, J., Kellerer, C., Deng, C., Peng, H., Rothfuss, O., Hussain, R. Z., Gocke, A. R., Respa, A., Glocova, I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100977 · Cited by 352
Self-citationEffect of IL-17A blockade with secukinumab in autoimmune diseases
Patel, D. D., Lee, D. M., Kolbinger, F., & Antoni, C. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202371 · Cited by 313
IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
Van Belle, A. B., de Heusch, M., Lemaire, M. M., Hendrickx, E., Warnier, G., Dunussi-Joannopoulos, K., Fouser, L. A., Renauld, J.-C., & Dumoutier, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102224 · Cited by 287 · cited 1×
“Overexpression of IL-22 results in psoriasis-like skin alterations in mice (36), and IL-22 deficiency protects mice from imiquimodinduced psoriasis-like skin inflammation (37).”
BackgroundIκBζ regulates TH17 development by cooperating with ROR nuclear receptors
Okamoto, K., Iwai, Y., Oh-hora, M., Yamamoto, M., Morio, T., Aoki, K., Ohya, K., Jetten, A. M., Akira, S., Muta, T., et al. (2010) · Nature · doi:10.1038/nature08922 · Cited by 265
Hierarchies of NF-κB target-gene regulation
Smale, S. T. (2011) · Nature Immunology · doi:10.1038/ni.2070 · Cited by 238 · cited 3×
“Whereas the rapid activation of primary response genes is directly induced by the classical NF-κB pathway, expression of so-called secondary response genes is delayed and requires prior protein synthesis of additional coregulators (13).”
BackgroundInfluentialIL-23–Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
Rizzo, H. L., Kagami, S., Phillips, K. G., Kurtz, S. E., Jacques, S. L., & Blauvelt, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001001 · Cited by 238 · cited 2×
“The essential role of IκBζ in psoriasis was not restricted to a TLR7/8-induced psoriasis-like skin inflammation, as similar results were obtained using the IL-23–induced psoriasis-like skin inflammation model, which is highly dependent on IL-17A signaling (24).”
ResultThe mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin
Johansen, C., Kragballe, K., Westergaard, M., Henningsen, J., Kristiansen, K., & Iversen, L. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06304.x · Cited by 205
Self-citationEnhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Tsoi, L. C., Spain, S. L., Ellinghaus, E., Stuart, P. E., Capon, F., Knight, J., Tejasvi, T., Kang, H. M., Allen, M. H., Lambert, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8001 · Cited by 195 · cited 2×
“Although IL-17 has been demonstrated to regulate IκBζ through an Act1-dependent mechanism in mice (46, 47) and humans (19), the exact signaling mechanism involved needs still to be determined.”
BackgroundMeta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease
Tian, S., Krueger, J. G., Li, K., Jabbari, A., Brodmerkel, C., Lowes, M. A., & Suárez-Fariñas, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044274 · Cited by 183 · cited 1×
“Because our in vitro data suggested that IκBζ is a transcriptional regulator of IL-17A– driven effects, and thus could play a role in the pathogenesis of psoriasis, and because previous transcriptome analyses of psoriasis biopsies have shown NFKBIZ to be up-regulated in psoriatic skin (21, 22), we next examined the ex…”
ResultMease, P. J. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000147 · Cited by 171 · cited 1×
“Furthermore, in two phase III clinical trials, secukinumab has shown significant and sustained efficacy compared with placebo in patients with psoriatic arthritis (9).”
BackgroundIL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms
Ha, H.-L., Wang, H., Pisitkun, P., Kim, J.-C., Tassi, I., Tang, W., Morasso, M. I., Udey, M. C., & Siebenlist, U. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400513111 · Cited by 171 · cited 1×
“The adaptor protein Act1 is one of the key components in the IL-17 signaling pathway (44), and recently Act1-mediated signaling was demonstrated to play an essential role in imiquimodinduced psoriasis-like skin inflammation (45).”
BackgroundIL-1β-Specific Up-Regulation of Neutrophil Gelatinase-Associated Lipocalin Is Controlled by IκB-ζ
Cowland, J. B., Muta, T., & Borregaard, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5559 · Cited by 151
Karlsen, J. R., Borregaard, N., & Cowland, J. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017129 · Cited by 146
Johansen, C., Funding, A. T., Otkjaer, K., Kragballe, K., Jensen, U. B., Madsen, M., Binderup, L., Skak-Nielsen, T., Fjording, M. S., & Iversen, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1431 · Cited by 139
Self-citationYamazaki, S., Muta, T., Matsuo, S., & Takeshige, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409983200 · Cited by 128
Secukinumab: First Global Approval
Sanford, M., & McKeage, K. (2015) · Drugs · doi:10.1007/s40265-015-0359-0 · Cited by 118
Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment
Papp, K. A., Leonardi, C. L., Menter, A., Thompson, E. H. Z., Milmont, C. E., Kricorian, G., Nirula, A., & Klekotka, P. A. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.08.039 · Cited by 116
Gordon, K. B., Leonardi, C. L., Lebwohl, M., Blauvelt, A., Cameron, G. S., Braun, D. K., Erickson, J., & Heffernan, M. P. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.07.048 · Cited by 112
Ejarque, R. A., Rittig, A. H., Johansen, C., Kragballe, K., & Iversen, L. (2013) · Experimental Dermatology · doi:10.1111/exd.12128 · Cited by 111
Self-citationIκBζ Is a Transcriptional Key Regulator of CCL2/MCP-1
Hildebrand, D. G., Alexander, E., Hörber, S., Lehle, S., Obermayer, K., Münck, N.-A., Rothfuss, O., Frick, J.-S., Morimatsu, M., Schmitz, I., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300089 · Cited by 94
Self-citationTrinh, D. V., Zhu, N., Farhang, G., Kim, B., & Huxford, T. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.060 · Cited by 86
Kao, C.-Y., Kim, C., Huang, F., & Wu, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708289200 · Cited by 80
Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation
Matsuo, S., Yamazaki, S., Takeshige, K., & Muta, T. (2007) · Biochemical Journal · doi:10.1042/bj20061797 · Cited by 70
Wang, C. Q. F., Suárez‐Fariñas, M., Nograles, K. E., Mimoso, C. A., Shrom, D., Dow, E. R., Heffernan, M. P., Hoffman, R. W., & Krueger, J. G. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.268 · Cited by 59
Johansen, C., Flindt, E. N., Kragballe, K., Henningsen, J., Westergaard, M., Kristiansen, K., & Iversen, L. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23749.x · Cited by 58
Self-citationTargeted Disruption of MAIL, a Nuclear IκB Protein, Leads to Severe Atopic Dermatitis-like Disease
Shiina, T., Konno, A., Oonuma, T., Kitamura, H., Imaoka, K., Takeda, N., Todokoro, K., & Morimatsu, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409770200 · Cited by 53
Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro
Kragballe, K., Desjarlais, L., & Marcelo, C. L. (1985) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1985.tb04852.x · Cited by 53 · cited 1×
“Normal human keratinocytes were obtained by trypsinization of skin samples from adult patients undergoing plastic surgery as previously described (49).”
MethodSønder, S. U., Paun, A., Ha, H.-L., Johnson, P. F., & Siebenlist, U. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103233 · Cited by 27
Ueta, M., Hamuro, J., Ueda, E., Katoh, N., Yamamoto, M., Takeda, K., Akira, S., & Kinoshita, S. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1691 · Cited by 22
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis
Bambouskova, M., Gorvel, L., Lampropoulou, V., Sergushichev, A., Loginicheva, E., Johnson, K., Korenfeld, D., Mathyer, M. E., Kim, H., Huang, L.-H., et al. (2018) · Nature · doi:10.1038/s41586-018-0052-z · Cited by 713
IL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
The role of itaconate in host defense and inflammation
Peace, C. G., & O’Neill, L. A. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148548 · Cited by 444
Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis
Kakiuchi, N., Yoshida, K., Uchino, M., Kihara, T., Akaki, K., Inoue, Y., Kawada, K., Nagayama, S., Yokoyama, A., Yamamoto, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1856-1 · Cited by 256
Metadata
- Authors
- Johansen, C., Mose, M., Ommen, P., Bertelsen, T., Vinter, H., Hailfinger, S., Lorscheid, S., Schulze-Osthoff, K., & Iversen, L.
- Affiliations
- Aarhus University Hospital (DK)
- University of Tübingen (DE)
- Department of Molecular Medicine, Interfaculty Institute for Biochemistry, Eberhard Karls University, D-72076 Tübingen, Germany;
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-10-12
- Volume
- 112
- Issue
- 43
- Pages
- E5825-33
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2144362153
- Cited by
- 125
- References
- 51
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 10 · 2023: 6 · 2022: 16 · 2021: 14 · 2020: 8 · 2019: 18 · 2018: 12 · 2017: 9 · 2016: 12 · 2015: 1
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sundhed og Sygdom, Det Frie Forskningsråd
- Deutsche Forschungsgemeinschaft (SFB 685)
- Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- IκB, psoriasis, NF-κB signaling, IL-17A, TNF-α, keratinocytes, skin inflammation, IL-23, transcriptional activation, siRNA knockdown, therapeutic target
- MeSH terms
- Imiquimod, Aminoquinolines, Animals, Humans, Psoriasis, I-kappa B Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.